[Prehepatectomy chemotherapy using hepatic artery infusion plus systemic chemotherapy for liver metastases from colorectal cancer]. 2010

Kuniya Tanaka, and Takafumi Kumamoto, and Kazunori Nojiri, and Ryotaro Mori, and Ryusei Matsuyama, and Kazuhisa Takeda, and Mitsuyoshi Ota, and Hirotoshi Akiyama, and Yasushi Ichikawa, and Itaru Endo
Dept. of Gastroenterological Surgery, Yokohama City University School of Medicine.

The purpose of this study was to determine the efficacy of hepatic artery infusion (HAI) plus systemic chemotherapy (SYS) as the prehepatectomy chemotherapy for liver metastases from colorectal cancer. Clinicopathologic data were available for 117 patients who were treated with chemotherapy before liver surgery. Response rate of chemotherapy and frequency of liver resection after chemotherapy of patients treated with HAI/SYS (n=26; 65% and 96%, respectively) were higher than those treated with HAI alone (n=63; 41% and 70%) or SYS alone (n=28; 25% and 42%). Histological examination of adjacent nonneoplastic liver confirmed that severe sinusoidal dilatation was less frequent in HAI/SYS group than in SYS group, and moderate to severe steatosis was also less frequent in HAI/SYS group as compared to HAI group. The combination of regional HAI and systemic chemotherapy is an effective prehepatectomy regimen for the treatment of patients with aggressive liver metastases from colorectal cancer.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009944 Organoplatinum Compounds Organic compounds which contain platinum as an integral part of the molecule. Compounds, Organoplatinum
D002166 Camptothecin An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. Camptothecine
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006498 Hepatectomy Excision of all or part of the liver. (Dorland, 28th ed) Hepatectomies

Related Publications

Kuniya Tanaka, and Takafumi Kumamoto, and Kazunori Nojiri, and Ryotaro Mori, and Ryusei Matsuyama, and Kazuhisa Takeda, and Mitsuyoshi Ota, and Hirotoshi Akiyama, and Yasushi Ichikawa, and Itaru Endo
February 2022, Gan to kagaku ryoho. Cancer & chemotherapy,
Kuniya Tanaka, and Takafumi Kumamoto, and Kazunori Nojiri, and Ryotaro Mori, and Ryusei Matsuyama, and Kazuhisa Takeda, and Mitsuyoshi Ota, and Hirotoshi Akiyama, and Yasushi Ichikawa, and Itaru Endo
July 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Kuniya Tanaka, and Takafumi Kumamoto, and Kazunori Nojiri, and Ryotaro Mori, and Ryusei Matsuyama, and Kazuhisa Takeda, and Mitsuyoshi Ota, and Hirotoshi Akiyama, and Yasushi Ichikawa, and Itaru Endo
January 1990, Cleveland Clinic journal of medicine,
Kuniya Tanaka, and Takafumi Kumamoto, and Kazunori Nojiri, and Ryotaro Mori, and Ryusei Matsuyama, and Kazuhisa Takeda, and Mitsuyoshi Ota, and Hirotoshi Akiyama, and Yasushi Ichikawa, and Itaru Endo
February 2003, Lancet (London, England),
Kuniya Tanaka, and Takafumi Kumamoto, and Kazunori Nojiri, and Ryotaro Mori, and Ryusei Matsuyama, and Kazuhisa Takeda, and Mitsuyoshi Ota, and Hirotoshi Akiyama, and Yasushi Ichikawa, and Itaru Endo
December 2000, Gan to kagaku ryoho. Cancer & chemotherapy,
Kuniya Tanaka, and Takafumi Kumamoto, and Kazunori Nojiri, and Ryotaro Mori, and Ryusei Matsuyama, and Kazuhisa Takeda, and Mitsuyoshi Ota, and Hirotoshi Akiyama, and Yasushi Ichikawa, and Itaru Endo
September 2023, Surgery,
Kuniya Tanaka, and Takafumi Kumamoto, and Kazunori Nojiri, and Ryotaro Mori, and Ryusei Matsuyama, and Kazuhisa Takeda, and Mitsuyoshi Ota, and Hirotoshi Akiyama, and Yasushi Ichikawa, and Itaru Endo
October 2008, Surgical oncology clinics of North America,
Kuniya Tanaka, and Takafumi Kumamoto, and Kazunori Nojiri, and Ryotaro Mori, and Ryusei Matsuyama, and Kazuhisa Takeda, and Mitsuyoshi Ota, and Hirotoshi Akiyama, and Yasushi Ichikawa, and Itaru Endo
October 2020, European journal of cancer (Oxford, England : 1990),
Kuniya Tanaka, and Takafumi Kumamoto, and Kazunori Nojiri, and Ryotaro Mori, and Ryusei Matsuyama, and Kazuhisa Takeda, and Mitsuyoshi Ota, and Hirotoshi Akiyama, and Yasushi Ichikawa, and Itaru Endo
July 2009, The Cochrane database of systematic reviews,
Kuniya Tanaka, and Takafumi Kumamoto, and Kazunori Nojiri, and Ryotaro Mori, and Ryusei Matsuyama, and Kazuhisa Takeda, and Mitsuyoshi Ota, and Hirotoshi Akiyama, and Yasushi Ichikawa, and Itaru Endo
January 2002, Cancer journal (Sudbury, Mass.),
Copied contents to your clipboard!